Platelet GPIIb/IIIa (P1A1/2) polymorphism in SLE: Clinical and laboratory association

Annals of the Rheumatic Diseases

Volumn 62, Issue 8, 2003, Pages 781-782

  Tolusso, B ^a   Fabris, M ^a   Gremese, E ^a   Mosca, M ^b   Rovere Querini, P ^c   Ferraccioli, G F ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; FIBRINOGEN RECEPTOR; GENE PRODUCT;

ADULT; AGED; ALLELISM; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULITIS;

ADULT; ALLELES; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RAYNAUD DISEASE;

EID: 0037998823     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.8.781     Document Type: Article

References (7)

1. Savi M, Ferraccioli GF, Neri TM, Zanelli P, Dall'Aglio PP, Tincani A, et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988;31:1568-70.
2. Weiss EJ, Bray PF, Tayback M. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-4.
3. ACR, ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology Nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
5. Bray PF. Platelet glycoprotein polymorphisms as risk factors for thombosis. Curr Opin Hematol 2000;7:284-9.
6. Byzova TV, Plow EF. The P1A2 allele and cardiovascular disease: the pros and cons. J Clin Invest 2000;105:697-8.
7. Sobel RE, Bray PF, Richardson C, Petri M, Salmon JE. The platelet glycoprotein IIIa polymorphism P1A2 and risk of thrombotic events in patients with antiphospolipid antibodies [abstract]. Arthritis Rheum 1998;41(suppl 9):S172.